Treatment option:
Medically reviewed by Kovalenko Svetlana Olegovna, PharmD. Last updated on 26.06.2023
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Special precautions for storage
Do not store above 25°C
In order to protect from light, keep the blister in the outer carton.
Nature and contents of container
DULCOLAX 10 mg Suppositories are presented in aluminium foil blister strips coated with polyethylene.
Pack sizes of 6, 10, 12, 20, 50 and 200.
Not all pack sizes may be marketed.
Special precautions for disposal and other handling
None stated.
Marketing authorisation holder
Aventis Pharma Limited
One Onslow Street
Guildford
Surrey
GU1 4YS
United Kingdom
Trading as:
Sanofi
One Onslow Street
Guildford
Surrey
GU1 4YS
United Kingdom
Marketing authorisation number(s)
PL 04425/0716
Date of first authorisation/renewal of the authorisation
22 January 1992 / 25 February 2005
Date of revision of the text
December 2017
Special instructions
- R52.1 – Chronic intractable pain
- R52.2 – Other chronic pain
- R52.9 – Unspecified pain
ATC - Anatomical and therapeutic chemical classification
- R52.1 – Chronic intractable pain
- R52.2 – Other chronic pain
- R52.9 – Unspecified pain
Nosological classification (ICD-10)
- R52.1 – Chronic intractable pain
- R52.2 – Other chronic pain
- R52.9 – Unspecified pain
Available in countries
Austria
Bosnia & Herzegowina
Brazil
Bulgaria
Canada
China
Costa Rica
Croatia (Hrvatska)
Cyprus
Czech Republic
Denmark
Dominican Republic
Ecuador
El Salvador
France
Georgia
Germany
Greece
Guatemala
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Italy
Lebanon
Malaysia
Malta
Netherlands
New Zealand
Nicaragua
Norway
Oman
Panama
Peru
Philippines
Portugal
Romania
Russia
Serbia
Singapore
Slovakia
Sweden
Thailand
United Kingdom
USA
Vietnam